Skip to main content

Table 1 Background characteristics of the patients with vascular dementia (VD) ( X ¯ ± s )

From: Quantitative evaluation of severity of behavioral and psychological symptoms of dementia in patients with vascular dementia

Characteristic Number 1st week 24th week
Age (years)   60.2 ± 9.7
Sex (M/F)   39/17
Duration of VD (years)   6.9 ± 5.2
MMSE   12.1 ± 1.7 10.9 ± 1.6
Huperzine A (μg/d) n = 24 323.30 ± 173.9 358.30 ± 191.4
Aniracetam (mg/d) n = 26 489.6 ± 179.3 506.6 ± 108.7
Memantine Hydrochloride (mg/d) n = 30 6.67 ± 5.38 6.98 ± 4.47
 Donepezil Hydrochloride (mg/d) n = 16 8.21 ± 3.76 9.33 ± 6.94
 Rivastigmine (mg/d) n = 13 3.33 ± 1.66 3.75 ± 1.66
Galantamine Reminyl (mg/d) n = 16 25.65 ± 22.36 26.82 ± 22.91
  1. MMSE indicates Mini–mental state examination. Cognitive function drug administration: 1 class of drug 73.2%; 2 classes 23.6%; 3 classes 3.2%.